Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model

(1) Background: In general, it is known that continuity of care can contribute to an increase in patient satisfaction, reduce health care costs, and improve patient outcomes. A guarantee of continuity in pharmacotherapy is a big challenge facing Japanese health care as a system that encourages coope...

Full description

Saved in:
Bibliographic Details
Main Authors: Rie Sato, Syuichi Aoshima, Tommy Eriksson
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/12/6/184
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850085262968750080
author Rie Sato
Syuichi Aoshima
Tommy Eriksson
author_facet Rie Sato
Syuichi Aoshima
Tommy Eriksson
author_sort Rie Sato
collection DOAJ
description (1) Background: In general, it is known that continuity of care can contribute to an increase in patient satisfaction, reduce health care costs, and improve patient outcomes. A guarantee of continuity in pharmacotherapy is a big challenge facing Japanese health care as a system that encourages cooperation/collaboration for pharmacists with other health care professions is currently lacking. (2) Method: This is a narrative review. (3) Results: The Lund Integrated Medicine Management (LIMM) model describes a systematic approach to individuals and was developed in Sweden to optimize pharmacotherapy among elderly inpatients. The aim of the LIMM model is to provide patients with continuous pharmacotherapy at different levels of care. The LIMM model, in which a clinical pharmacist is the catalyst and leads other health care professions in completing the process, has the potential to reduce potentially inappropriate prescriptions, reduce rehospitalization risk, unscheduled hospital revisits due to problems related to medications, reduce total medical expenditure, and provide a comprehensive understanding of patients’ conditions of taking medicine. (4) Conclusions: Introducing a framework such as Sweden’s LIMM model, anchored by clinical pharmacists, could provide a good opportunity to promote collaborations among different health care professionals and improve continuity in pharmacotherapy.
format Article
id doaj-art-410f722a42e844e5a07ed04815cb8f5d
institution DOAJ
issn 2226-4787
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Pharmacy
spelling doaj-art-410f722a42e844e5a07ed04815cb8f5d2025-08-20T02:43:46ZengMDPI AGPharmacy2226-47872024-12-0112618410.3390/pharmacy12060184Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) ModelRie Sato0Syuichi Aoshima1Tommy Eriksson2Center for Primary Health Care Research, Department of Clinical Sciences, Faculty of Medicine, Lund University, CRC 28-11, Jan Waldenströms Gata 35, Box 50332, SE202-13 Malmö, SwedenMedical Corporation Tokujin-kai, Nakano Hospital, 8-1, Iwai-cho, Tochigi City 328-0052, Tochigi, JapanDepartment of Biomedical Science and Biofilm, Research Center for Biointerfaces, Faculty of Health and Society, Malmö University, SE205-06 Malmö, Sweden(1) Background: In general, it is known that continuity of care can contribute to an increase in patient satisfaction, reduce health care costs, and improve patient outcomes. A guarantee of continuity in pharmacotherapy is a big challenge facing Japanese health care as a system that encourages cooperation/collaboration for pharmacists with other health care professions is currently lacking. (2) Method: This is a narrative review. (3) Results: The Lund Integrated Medicine Management (LIMM) model describes a systematic approach to individuals and was developed in Sweden to optimize pharmacotherapy among elderly inpatients. The aim of the LIMM model is to provide patients with continuous pharmacotherapy at different levels of care. The LIMM model, in which a clinical pharmacist is the catalyst and leads other health care professions in completing the process, has the potential to reduce potentially inappropriate prescriptions, reduce rehospitalization risk, unscheduled hospital revisits due to problems related to medications, reduce total medical expenditure, and provide a comprehensive understanding of patients’ conditions of taking medicine. (4) Conclusions: Introducing a framework such as Sweden’s LIMM model, anchored by clinical pharmacists, could provide a good opportunity to promote collaborations among different health care professionals and improve continuity in pharmacotherapy.https://www.mdpi.com/2226-4787/12/6/184pharmacotherapycontinuity of careprimary health careclinical pharmaciststhe Lund Integrated Medicines Management (LIMM) modelSweden
spellingShingle Rie Sato
Syuichi Aoshima
Tommy Eriksson
Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model
Pharmacy
pharmacotherapy
continuity of care
primary health care
clinical pharmacists
the Lund Integrated Medicines Management (LIMM) model
Sweden
title Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model
title_full Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model
title_fullStr Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model
title_full_unstemmed Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model
title_short Clinical Pharmacist-Led Collaboration of Multiple Clinical Professions Model Focusing on Continuity of Pharmacotherapy: Japanese Version of the Lund Integrated Medicines Management (LIMM) Model
title_sort clinical pharmacist led collaboration of multiple clinical professions model focusing on continuity of pharmacotherapy japanese version of the lund integrated medicines management limm model
topic pharmacotherapy
continuity of care
primary health care
clinical pharmacists
the Lund Integrated Medicines Management (LIMM) model
Sweden
url https://www.mdpi.com/2226-4787/12/6/184
work_keys_str_mv AT riesato clinicalpharmacistledcollaborationofmultipleclinicalprofessionsmodelfocusingoncontinuityofpharmacotherapyjapaneseversionofthelundintegratedmedicinesmanagementlimmmodel
AT syuichiaoshima clinicalpharmacistledcollaborationofmultipleclinicalprofessionsmodelfocusingoncontinuityofpharmacotherapyjapaneseversionofthelundintegratedmedicinesmanagementlimmmodel
AT tommyeriksson clinicalpharmacistledcollaborationofmultipleclinicalprofessionsmodelfocusingoncontinuityofpharmacotherapyjapaneseversionofthelundintegratedmedicinesmanagementlimmmodel